PreveCeutical Medical Inc. (PRVCF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CAD | 0.0% |
| 2022 | - CAD | -100.0% |
| 2021 | 1.67 Million CAD | -10.66% |
| 2020 | 1.87 Million CAD | -46.54% |
| 2019 | 3.5 Million CAD | 15.3% |
| 2018 | 3.04 Million CAD | 15.32% |
| 2017 | 2.63 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 60.59 Thousand CAD | 0.0% |
| 2024 Q2 | 61.34 Thousand CAD | 1.23% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 FY | - CAD | 0.0% |
| 2022 Q1 | 1.72 Million CAD | 3.04% |
| 2022 FY | - CAD | -100.0% |
| 2022 Q3 | 60 Thousand CAD | -96.63% |
| 2022 Q2 | 1.78 Million CAD | 3.07% |
| 2022 Q4 | - CAD | -100.0% |
| 2021 Q3 | 1.5 Million CAD | 3.37% |
| 2021 FY | 1.67 Million CAD | -10.66% |
| 2021 Q2 | 1.45 Million CAD | 3.35% |
| 2021 Q1 | 1.41 Million CAD | -24.8% |
| 2021 Q4 | 1.67 Million CAD | 11.22% |
| 2020 Q4 | 1.87 Million CAD | 1.87% |
| 2020 Q2 | 1.72 Million CAD | -51.98% |
| 2020 FY | 1.87 Million CAD | -46.54% |
| 2020 Q1 | 3.58 Million CAD | 2.08% |
| 2020 Q3 | 1.84 Million CAD | 7.07% |
| 2019 FY | 3.5 Million CAD | 15.3% |
| 2019 Q4 | 3.5 Million CAD | -5.34% |
| 2019 Q3 | 3.7 Million CAD | 2.51% |
| 2019 Q1 | 3.68 Million CAD | 20.95% |
| 2019 Q2 | 3.61 Million CAD | -1.76% |
| 2018 Q3 | 2.63 Million CAD | 3.38% |
| 2018 FY | 3.04 Million CAD | 15.32% |
| 2018 Q4 | 3.04 Million CAD | 15.31% |
| 2018 Q2 | 2.55 Million CAD | -6.64% |
| 2018 Q1 | 2.73 Million CAD | 3.62% |
| 2017 Q2 | 2.32 Million CAD | 0.0% |
| 2017 Q4 | 2.63 Million CAD | 12.02% |
| 2017 FY | 2.63 Million CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q3 | 2.35 Million CAD | 1.33% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |